Details for New Drug Application (NDA): 070185
✉ Email this page to a colleague
NDA 070185 describes FLUOR-OP, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the FLUOR-OP profile page.
The generic ingredient in FLUOR-OP is fluorometholone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluorometholone profile page.
The generic ingredient in FLUOR-OP is fluorometholone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluorometholone profile page.
Summary for 070185
| Tradename: | FLUOR-OP |
| Applicant: | Novartis |
| Ingredient: | fluorometholone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070185
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
| Approval Date: | Feb 27, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
